Posted inBiotechnology
Tirzepatide Shows Promise for Non-Diabetic Weight Loss
In a groundbreaking real-world clinical study, researchers have unveiled compelling evidence supporting the efficacy and tolerability of low-dose tirzepatide, a…
Posted inBiotechnology
Low-Dose Irradiation Boosts Antioxidants in Produce
In a groundbreaking study poised to redefine the paradigms of postharvest technology, researchers Kim, de Jesus Ornelas-Paz, and Prakash have…
Posted inBiotechnology
Defect Engineering in SnO2 Enhances Sodium Storage Anodes
In the ever-evolving landscape of energy storage technologies, the quest for efficient and sustainable batteries has driven extensive research into…
Posted inGenetics
Drug Discovery Innovation: Target Deconvolution and Tractability Assessment
Target deconvolution, particularly when paired with proteomics techniques, plays a crucial role in drug screening, covalent drug discovery, mechanism of…
Posted inBiotechnology
GSK cuts the cord on Ideaya collaboration, letting go of 2 programs
GSK is officially cutting ties with Ideaya Biosciences, handing back two clinical programs as part of the termination of a…
Posted inGenetics
Meet the Next Generation of Benchtop Sequencing Systems
View eBook With the MiSeq™ i100 Series, Illumina continues to set the highest standards. Advancements in system design, sequencing chemistry,…
Posted inGenetics
NeurIPS 2025: Altos Labs Wins Generalist Prize at Arc’s Virtual Cell Challenge
San Diego – The results from Arc Institute’s inaugural Virtual Cell Challenge are in. The public competition, sponsored by Nvidia, 10x Genomics, and Ultima Genomics, declared not one, but two grand prizes,…
Posted inBiotechnology
ASH: Merck mulls future of polycythemia program while Takeda takes phase 3 victory lap
Patients with polycythemia vera (PV), a rare cancer characterized by overabundant red blood cells, have endured years of middling progress…
Posted inMedical Technology
FDA clears Resmed AI for personalizing CPAP settings
Resmed believes its artificial intelligence-powered approach to personalizing the settings of its connected CPAP machines can lead to better sleep…
Posted inBiotechnology
Dyne readies FDA push after DMD exon 51 med excels in trial
Nine years after Sarepta Therapeutics’ Exondys 51 won a controversial FDA approval to treat a subset of patients with Duchenne…